1
|
Polymeric solid dispersion Vs co-amorphous technology: A critical comparison. J Drug Deliv Sci Technol 2022. [DOI: 10.1016/j.jddst.2022.103980] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
2
|
Du Y, Phyo P, Li M, Sorman B, McNevin M, Xu W, Liu Y, Su Y. Quantifying Micromolar Crystallinity in Pharmaceutical Materials Utilizing 19F Solid-State NMR. Anal Chem 2022; 94:15341-15349. [DOI: 10.1021/acs.analchem.2c02828] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Yong Du
- Analytical Research and Development, Merck & Co. Inc., Rahway, New Jersey07065, United States
| | - Pyae Phyo
- Analytical Research and Development, Merck & Co. Inc., Rahway, New Jersey07065, United States
| | - Mingyue Li
- Analytical Research and Development, Merck & Co. Inc., Rahway, New Jersey07065, United States
| | - Bradley Sorman
- Analytical Research and Development, Merck & Co. Inc., Rahway, New Jersey07065, United States
| | - Michael McNevin
- Analytical Research and Development, Merck & Co. Inc., Rahway, New Jersey07065, United States
| | - Wei Xu
- Analytical Research and Development, Merck & Co. Inc., Rahway, New Jersey07065, United States
| | - Yong Liu
- Analytical Research and Development, Merck & Co. Inc., Rahway, New Jersey07065, United States
| | - Yongchao Su
- Analytical Research and Development, Merck & Co. Inc., Rahway, New Jersey07065, United States
| |
Collapse
|
3
|
Du Y, Su Y. 19F Solid-state NMR characterization of pharmaceutical solids. SOLID STATE NUCLEAR MAGNETIC RESONANCE 2022; 120:101796. [PMID: 35688018 DOI: 10.1016/j.ssnmr.2022.101796] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/09/2022] [Revised: 05/18/2022] [Accepted: 05/19/2022] [Indexed: 06/15/2023]
Abstract
Solid-state NMR has been increasingly recognized as a high-resolution and versatile spectroscopic tool to characterize drug substances and products. However, the analysis of pharmaceutical materials is often carried out at natural isotopic abundance and a relatively low drug loading in multi-component systems and therefore suffers from challenges of low sensitivity. The fact that fluorinated therapeutics are well represented in pipeline drugs and commercial products offers an excellent opportunity to utilize fluorine as a molecular probe for pharmaceutical analysis. We aim to review recent advancements of 19F magic angle spinning NMR methods in modern drug research and development. Applications to polymorph screening at the micromolar level, structural elucidation, and investigation of molecular interactions at the Ångström to submicron resolution in drug delivery, stability, and quality will be discussed.
Collapse
Affiliation(s)
- Yong Du
- Analytical Research and Development, Merck & Co., Inc., Rahway, NJ, 07065, United States
| | - Yongchao Su
- Analytical Research and Development, Merck & Co., Inc., Rahway, NJ, 07065, United States; Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, IN, 47907, United States; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, 78712, United States; Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT, 06269, United States.
| |
Collapse
|
4
|
Li Q, Kölbel J, Davis MP, Korter TM, Bond AD, Threlfall T, Zeitler JA. In Situ Observation of the Structure of Crystallizing Magnesium Sulfate Heptahydrate Solutions with Terahertz Transmission Spectroscopy. CRYSTAL GROWTH & DESIGN 2022; 22:3961-3972. [PMID: 35673396 PMCID: PMC9165030 DOI: 10.1021/acs.cgd.2c00352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/22/2022] [Revised: 05/05/2022] [Indexed: 06/15/2023]
Abstract
Terahertz time-domain spectroscopy in a transmission geometry combined with visual analysis was used to investigate the crystallization process of MgSO4 solution. Careful spectral analysis of both a feature at 1.6 THz and the overall magnitude of absorption allowed the extraction of information about the liquid phase before and during crystallization, aiding the investigation of solvation dynamics and the behavior of molecular species at phase boundaries. The method was reproducibly applied to a number of measurements on a series of solutions of three chosen concentrations at different temperatures. When increasing temperature at the end of the measurement, the dissolution of crystals was observed as well. The temperature-dependent absorption data of the semicrystalline systems were converted to the solvent concentrations using a recently developed method. Solutions of a series of concentrations were also investigated in the temperature range of 4-25 °C. The results were compared to the theoretical calculated values, and the consistent differences proved the existence of a hydration shell around the salt ions whose behavior is different from bulk water. Future work will focus on triggering nucleation at specific positions in order to study the very beginning of the crystallization process. MgSO4 heptahydrate is used as a model system in this study, while the concept and the setup can be applied to other systems.
Collapse
Affiliation(s)
- Qi Li
- Department
of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.
| | - Johanna Kölbel
- Department
of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.
| | - Margaret P. Davis
- Department
of Chemistry, Syracuse University, 1-046 Center for Science and Technology, Syracuse, New York 13244, United States
| | - Timothy M. Korter
- Department
of Chemistry, Syracuse University, 1-046 Center for Science and Technology, Syracuse, New York 13244, United States
| | - Andrew D. Bond
- Yusuf
Hamied Department of Chemistry, University
of Cambridge, Lensfield
Road, Cambridge CB2 1EW, U.K.
| | - Terrence Threlfall
- Department
of Chemistry, University of Southampton, University Road, Southampton SO17 1BJ, U.K.
| | - J. Axel Zeitler
- Department
of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.
| |
Collapse
|
5
|
Surface nanocoating of high drug-loading spray-dried amorphous solid dispersions by atomic layer coating: Excellent physical stability under accelerated storage conditions for two years. Int J Pharm 2022; 620:121747. [DOI: 10.1016/j.ijpharm.2022.121747] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2022] [Revised: 04/05/2022] [Accepted: 04/09/2022] [Indexed: 12/24/2022]
|
6
|
Kölbel J, Li Q, Threlfall TL, Zeitler JA. Measuring Solute Concentration with Terahertz Time-Domain Spectroscopy in Single and Multiphase Systems. Anal Chem 2022; 94:1713-1716. [DOI: 10.1021/acs.analchem.1c04279] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Johanna Kölbel
- Department of Chemical Engineering, University of Cambridge, Cambridge CB3 0AS, United Kingdom
| | - Qi Li
- Department of Chemical Engineering, University of Cambridge, Cambridge CB3 0AS, United Kingdom
| | - Terence L. Threlfall
- Department of Chemistry, University of Southampton, Southampton SO17 1BJ, United Kingdom
| | - J. Axel Zeitler
- Department of Chemical Engineering, University of Cambridge, Cambridge CB3 0AS, United Kingdom
| |
Collapse
|
7
|
Formulating a heat- and shear-labile drug in an amorphous solid dispersion: Balancing drug degradation and crystallinity. Int J Pharm X 2021; 3:100092. [PMID: 34977559 PMCID: PMC8683684 DOI: 10.1016/j.ijpx.2021.100092] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2021] [Accepted: 07/12/2021] [Indexed: 12/02/2022] Open
Abstract
We seek to further addresss the questions posed by Moseson et al. regarding whether any residual crystal level, size, or characteristic is acceptable in an amorphous solid dispersion (ASD) such that its stability, enhanced dissolution, and increased bioavailability are not compromised. To address this highly relevant question, we study an interesting heat- and shear-labile drug in development, LY3009120. To study the effects of residual crystallinity and degradation in ASDs, we prepared three compositionally identical formulations (57–1, 59–4, and 59–5) using the KinetiSol process under various processing conditions to obtain samples with various levels of crystallinity (2.3%, 0.9%, and 0.1%, respectively) and degradation products (0.74%, 1.97%, and 3.12%, respectively). Samples with less than 1% crystallinity were placed on stability, and we observed no measurable change in the drug's crystallinity, dissolution profile or purity in the 59–4 and 59–5 formulations over four months of storage under closed conditions at 25 °C and 60% humidity. For formulations 57–1, 59–4, and 59–5, bioavailability studies in rats reveal a 44-fold, 55-fold, and 62-fold increase in mean AUC, respectively, compared to the physical mixture. This suggests that the presence of some residual crystals after processing can be acceptable and will not change the properties of the ASD over time.
Collapse
|
8
|
Sherman AM, Takanti N, Rong J, Simpson GJ. Nonlinear optical characterization of pharmaceutical formulations. Trends Analyt Chem 2021. [DOI: 10.1016/j.trac.2021.116241] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
9
|
|
10
|
Sahakijpijarn S, Moon C, Ma X, Su Y, Koleng JJ, Dolocan A, Williams RO. Using thin film freezing to minimize excipients in inhalable tacrolimus dry powder formulations. Int J Pharm 2020; 586:119490. [PMID: 32603840 DOI: 10.1016/j.ijpharm.2020.119490] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2020] [Revised: 05/27/2020] [Accepted: 05/28/2020] [Indexed: 02/09/2023]
Abstract
We investigated the feasibility of preparing high-potency tacrolimus dry powder for inhalation using thin film freezing (TFF). We found that using ultra-rapid freezing can increase drug loading up to 95% while maintaining good aerosol performance. Drug loading affected the specific surface area and moisture sorption of TFF formulations, but it did not affect the chemical stability, physical stability, and dissolution of tacrolimus. Tacrolimus remained amorphous after storage at 40 °C/75% RH, and 25 °C/60% RH for up to 6 months. Lactose functioned as a bulking agent, and it had little to no effect as a stabilizer for amorphous tacrolimus due to a lack of interaction between the drug and excipient. Additionally, the aerosol performance of TFF tacrolimus/lactose (95/5) did not significantly change after six months of storage at 25 °C/60% RH. For processing parameters, the solids content and the processing temperature did not affect the aerosol performance of tacrolimus. Furthermore, both low- and high-resistance RS01 showed optimal and consistent aerosol performance over the 1-4 kPa pressure drop range. In conclusion, TFF is a suitable technology for producing inhalable powder that contain high drug loading and have less flow rate dependence.
Collapse
Affiliation(s)
- Sawittree Sahakijpijarn
- The University of Texas at Austin, College of Pharmacy, Division of Molecular Pharmaceutics and Drug Delivery, Austin, TX, USA
| | - Chaeho Moon
- The University of Texas at Austin, College of Pharmacy, Division of Molecular Pharmaceutics and Drug Delivery, Austin, TX, USA; TFF Pharmaceuticals, Inc., Austin, TX, USA
| | - Xiangyu Ma
- The University of Texas at Austin, College of Pharmacy, Division of Molecular Pharmaceutics and Drug Delivery, Austin, TX, USA
| | - Yongchao Su
- Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ, USA
| | | | - Andrei Dolocan
- The University of Texas at Austin, Texas Materials Institute, Austin, TX, USA
| | - Robert O Williams
- The University of Texas at Austin, College of Pharmacy, Division of Molecular Pharmaceutics and Drug Delivery, Austin, TX, USA.
| |
Collapse
|
11
|
Webster GK, Pommerening CA, Harman WW, Gragg MA, Han JH, Taylor DJ. Exploiting Kinetic Solubility Differences for Low Level Detection of Crystallinity in Amorphous Drug Formulations. CURR PHARM ANAL 2020. [DOI: 10.2174/1573412915666181210144338] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Background:
Enabling formulations have been implemented by the pharmaceutical industry
as an effective tool for keeping Active Pharmaceutical Ingredient (API) in an amorphous state. Upon
dosing in the amorphous state, many drugs which fail to demonstrate bioactivity due to the limited solubility
and bioavailability of their crystalline form become bioavailable.
Purpose:
The analytical techniques use today for crystallinity detection are challenged by the sensitivity
and robustness needed to achieve a 5% quantitation limit in low dose drug products. Our laboratory has
developed a novel procedure capable of meeting this sensitivity and selectivity requirement. This is
achieved by exploiting the differences in kinetic solubility of the formulated amorphous and free crystalline
forms of API currently being used in dosage form platforms.
Methods:
Representative amorphous drug formulations were prepared and spiked with varying levels of
crystalline drug substances to evaluate the selectivity and recovery of the crystalline drug substance
from the product formulation. Kinetic solubility testing using a (i) Particle wetting phase, (ii) Particle
suspending/erosion phase, (iii) Sampling time point and (iv) A total recovery determination for the drug
substance.
Results:
The method selectively and quantitatively distinguishes crystalline drug substance from amorphous
drug substance for samples spiked from 2.5% to 10% of the nominal label concentration of the
API in the dosage form matrix.
Conclusion:
The kinetic solubility approach reported here achieves sensitive crystallinity quantitation
for low drug level amorphous drug formulations at levels not yet achieved by complimentary analytical
techniques.
Collapse
Affiliation(s)
- Gregory K. Webster
- Research & Development Department, AbbVie Inc., North Chicago, IL 60064, United States
| | | | - Whitney W. Harman
- Research & Development Department, AbbVie Inc., North Chicago, IL 60064, United States
| | - Mathew A. Gragg
- Research & Development Department, AbbVie Inc., North Chicago, IL 60064, United States
| | - Jian-Hwa Han
- Research & Development Department, AbbVie Inc., North Chicago, IL 60064, United States
| | - Daniel J. Taylor
- Research & Development Department, AbbVie Inc., North Chicago, IL 60064, United States
| |
Collapse
|
12
|
Mašková E, Kubová K, Raimi-Abraham BT, Vllasaliu D, Vohlídalová E, Turánek J, Mašek J. Hypromellose - A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery. J Control Release 2020; 324:695-727. [PMID: 32479845 DOI: 10.1016/j.jconrel.2020.05.045] [Citation(s) in RCA: 88] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2020] [Revised: 05/27/2020] [Accepted: 05/27/2020] [Indexed: 02/07/2023]
Abstract
Hydroxypropylmethylcellulose (HPMC), also known as Hypromellose, is a traditional pharmaceutical excipient widely exploited in oral sustained drug release matrix systems. The choice of numerous viscosity grades and molecular weights available from different manufacturers provides a great variability in its physical-chemical properties and is a basis for its broad successful application in pharmaceutical research, development, and manufacturing. The excellent mucoadhesive properties of HPMC predetermine its use in oromucosal delivery systems including mucoadhesive tablets and films. HPMC also possesses desirable properties for formulating amorphous solid dispersions increasing the oral bioavailability of poorly soluble drugs. Printability and electrospinnability of HPMC are promising features for its application in 3D printed drug products and nanofiber-based drug delivery systems. Nanoparticle-based formulations are extensively explored as antigen and protein carriers for the formulation of oral vaccines, and oral delivery of biologicals including insulin, respectively. HPMC, being a traditional pharmaceutical excipient, has an irreplaceable role in the development of new pharmaceutical technologies, and new drug products leading to continuous manufacturing processes, and personalized medicine. This review firstly provides information on the physical-chemical properties of HPMC and a comprehensive overview of its application in traditional oral drug formulations. Secondly, this review focuses on the application of HPMC in modern pharmaceutical technologies including spray drying, hot-melt extrusion, 3D printing, nanoprecipitation and electrospinning leading to the formulation of printlets, nanoparticle-, microparticle-, and nanofiber-based delivery systems for oral and oromucosal application. Hypromellose is an excellent excipient for formulation of classical dosage forms and advanced drug delivery systems. New methods of hypromellose processing include spray draying, hot-melt extrusion, 3D printing, and electrospinning.
Collapse
Affiliation(s)
- Eliška Mašková
- Department of Pharmacology and Immunotherapy, Veterinary Research Institute, Hudcova 70, Brno 621 00, Czech Republic
| | - Kateřina Kubová
- Faculty of Pharmacy, Masaryk University, Brno 625 00, Czech Republic
| | - Bahijja T Raimi-Abraham
- School of Cancer and Pharmaceutical Sciences, King's College London, 150 Stamford Street, London SE1 9NH, United Kingdom
| | - Driton Vllasaliu
- School of Cancer and Pharmaceutical Sciences, King's College London, 150 Stamford Street, London SE1 9NH, United Kingdom
| | - Eva Vohlídalová
- Department of Pharmacology and Immunotherapy, Veterinary Research Institute, Hudcova 70, Brno 621 00, Czech Republic
| | - Jaroslav Turánek
- Department of Pharmacology and Immunotherapy, Veterinary Research Institute, Hudcova 70, Brno 621 00, Czech Republic.
| | - Josef Mašek
- Department of Pharmacology and Immunotherapy, Veterinary Research Institute, Hudcova 70, Brno 621 00, Czech Republic.
| |
Collapse
|
13
|
Moris M, Van Den Eede MP, Koeckelberghs G, Deschaume O, Bartic C, Van Cleuvenbergen S, Clays K, Verbiest T. Harmonic light scattering study reveals structured clusters upon the supramolecular aggregation of regioregular poly(3-alkylthiophene). Commun Chem 2019. [DOI: 10.1038/s42004-019-0230-4] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
Abstract
Solubilized poly(3-alkylthiophene)s are known to self-assemble into well-ordered supramolecular aggregates upon lowering the solvent quality. This supramolecular organization largely determines the optical and electronic properties of these polymers. However, despite numerous studies the exact mechanism and kinetics of the aggregation process and the role of external stimuli are still poorly understood. Classical characterization techniques such as electronic spectroscopy, dynamic light scattering, and diffraction-based techniques have not been able to provide a full understanding. Here we use second-harmonic scattering (SHS) and third-harmonic scattering (THS) techniques to investigate this supramolecular aggregation mechanism. Our results indicate that the actual supramolecular aggregation is preceded by the formation of structured polymer-solvent clusters consistent with a nonclassical crystallization pathway.
Collapse
|
14
|
Ricarte RG, Van Zee NJ, Li Z, Johnson LM, Lodge TP, Hillmyer MA. Recent Advances in Understanding the Micro- and Nanoscale Phenomena of Amorphous Solid Dispersions. Mol Pharm 2019; 16:4089-4103. [PMID: 31487183 DOI: 10.1021/acs.molpharmaceut.9b00601] [Citation(s) in RCA: 47] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Many pharmaceutical drugs in the marketplace and discovery pipeline suffer from poor aqueous solubility, thereby limiting their effectiveness for oral delivery. The use of an amorphous solid dispersion (ASD), a mixture of an active pharmaceutical ingredient and a polymer excipient, greatly enhances the aqueous dissolution performance of a drug without the need for chemical modification. Although this method is versatile and scalable, deficient understanding of the interactions between drugs and polymers inhibits ASD rational design. This current Review details recent progress in understanding the mechanisms that control ASD performance. In the solid-state, the use of high-resolution theoretical, computational, and experimental tools resolved the influence of drug/polymer phase behavior and dynamics on stability during storage. During dissolution in aqueous media, novel characterization methods revealed that ASDs can form complex nanostructures, which maintain and improve supersaturation of the drug. The studies discussed here illustrate that nanoscale phenomena, which have been directly observed and quantified, strongly affect the stability and bioavailability of ASD systems, and provide a promising direction for optimizing drug/polymer formulations.
Collapse
Affiliation(s)
- Ralm G Ricarte
- Molecular, Macromolecular Chemistry, and Materials Laboratory, CNRS, ESPCI-Paris , PSL Research University , 10 Rue Vauquelin , 75005 Paris , France
| | | | | | | | | | | |
Collapse
|
15
|
Moon C, Watts AB, Lu X, Su Y, Williams RO. Enhanced Aerosolization of High Potency Nanoaggregates of Voriconazole by Dry Powder Inhalation. Mol Pharm 2019; 16:1799-1812. [PMID: 30925839 DOI: 10.1021/acs.molpharmaceut.8b00907] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Invasive pulmonary aspergillosis is a deadly fungal infection with a high mortality rate, particularly in patients having undergone transplant surgery. Voriconazole, a triazole antifungal pharmaceutical product, is considered as a first-line therapy for invasive pulmonary aspergillosis, and exhibits efficacy even for patients who have failed other antifungal drug therapies. The objective of this study is to develop high potency nanoaggregates of crystalline voriconazole composition for dry powder inhalation using the particle engineering process, thin film freezing. In this study, mannitol at low concentrations acted as a surface texture-modifying agent, and we evaluated the physicochemical and aerodynamic properties of the voriconazole formulations containing different amounts of mannitol. In vitro aerosol performance data demonstrated that powder formulations consisting of 90 to 97% (w/w) voriconazole were the optimum for inhalation with a fine particle fraction (% of delivered dose) as high as 73.6 ± 3.2% and mass median aerodynamic diameter of 3.03 ± 0.17 μm when delivered by a commercially available device. The thin film freezing process enabled phase-separated submicron crystalline mannitol to be oriented such as to modify the surface texture of the crystalline voriconazole nanoaggregates, thus enhancing their aerosolization. Addition of as low as 3% (w/w) mannitol significantly increased the fine particle fraction (% of metered dose) of voriconazole nanoaggregates when compared to compositions without mannitol (40.8% vs 24.6%, respectively). The aerosol performance of the voriconazole nanoaggregates with 5% (w/w) mannitol was maintained for 13 months at 25 °C/60% RH. Therefore, voriconazole nanoaggregates having low amounts of surface texture-modifying mannitol made by thin film freezing are a feasible local treatment option for invasive pulmonary aspergillosis with high aerosolization efficiency and drug loading for dry powder inhalation.
Collapse
Affiliation(s)
- Chaeho Moon
- College of Pharmacy , The University of Texas at Austin , Austin , Texas 78712 , United States
| | - Alan B Watts
- College of Pharmacy , The University of Texas at Austin , Austin , Texas 78712 , United States
| | - Xingyu Lu
- Merck Research Laboratories , Merck & Co., Inc., Kenilworth , New Jersey 07033 , United States
| | - Yongchao Su
- Merck Research Laboratories , Merck & Co., Inc., Kenilworth , New Jersey 07033 , United States
| | - Robert O Williams
- College of Pharmacy , The University of Texas at Austin , Austin , Texas 78712 , United States
| |
Collapse
|
16
|
Smith CJ, Dinh J, Schmitt PD, Stroud PA, Hinds J, Johnson MJ, Simpson GJ. Calibration-Free Second Harmonic Generation (SHG) Image Analysis for Quantification of Trace Crystallinity Within Final Dosage Forms of Amorphous Solid Dispersions. APPLIED SPECTROSCOPY 2018; 72:1594-1605. [PMID: 29896972 DOI: 10.1177/0003702818786506] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
A statistical model enables auto-calibration of second harmonic generation (SHG) images for quantifying trace crystallinity within amorphous solid dispersions (ASDs) over a wide dynamic range of crystallinity. In this paper, we demonstrate particle-counting approaches for quantifying trace crystallinity, combined with analytical expressions correcting for particle overlap bias in higher crystallinity regimes to extend the continuous dynamic range of standard particle-counting algorithms through to the signal averaging regime. The reliability of the values recovered by these expressions was demonstrated with simulated data as well as experimental data obtained for an amorphous solid dispersion formulation containing evacetrapib, an Eli Lilly and Company compound. Since particle counting independently recovers the crystalline volume and the SHG intensity, the average SHG intensity per unit volume can be used as an internal calibrant for quantifying crystallinity at higher volume fractions, for which particle counting is no longer applicable.
Collapse
Affiliation(s)
- Casey J Smith
- 1 Department of Chemistry, Purdue University, West Lafayette, IN, USA
| | - Janny Dinh
- 1 Department of Chemistry, Purdue University, West Lafayette, IN, USA
| | - Paul D Schmitt
- 3 Department of Chemistry, Wabash College, Crawfordsville, IN, USA
| | | | | | | | - Garth J Simpson
- 1 Department of Chemistry, Purdue University, West Lafayette, IN, USA
| |
Collapse
|
17
|
Early stages of drug crystallization from amorphous solid dispersion via fractal analysis based on chemical imaging. Eur J Pharm Biopharm 2018; 133:122-130. [PMID: 30300718 DOI: 10.1016/j.ejpb.2018.10.007] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2018] [Revised: 09/03/2018] [Accepted: 10/05/2018] [Indexed: 12/30/2022]
Abstract
Early stages of crystallization from amorphous solid dispersion (ASD) are typically not detected by means of standard methods like powder X-ray diffraction (XRPD). The aim of this study is therefore to evaluate if fractal analysis based on energy dispersive X-ray imaging can provide the means to identify early signs of physical instability. ASDs of the poorly water-soluble compound, felodipine (FEL) were prepared by solvent evaporation using different grades of HPMCAS, at 50 wt% drug loading. Samples were stored at accelerated conditions of 40 °C. Scanning electron microscopy equipped with an energy-dispersive X-ray spectroscopy (SEM-EDS) was used for elemental mapping of tablet surfaces. Comparative data were generated with a standard XRPD and with more sensitive methods for detection of early instability, i.e. laser scanning confocal microscopy (LSM) and atomic force microscopy (AFM). The SEM-EDS identified changes of drug-rich domains that were confirmed by LSM and AFM. Early changes in drug clusters were also revealed by a multifractal analysis that indicated a beginning phase separation and drug crystallization. Therefore, the presented fractal cluster analysis based on chemical imaging bears much promise as a new method to detect early signs of physical instability in ASD, which is of great relevance for pharmaceutical development.
Collapse
|
18
|
Hirsh DA, Su Y, Nie H, Xu W, Stueber D, Variankaval N, Schurko RW. Quantifying Disproportionation in Pharmaceutical Formulations with 35Cl Solid-State NMR. Mol Pharm 2018; 15:4038-4048. [DOI: 10.1021/acs.molpharmaceut.8b00470] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Affiliation(s)
- David A. Hirsh
- Department of Chemistry & Biochemistry, University of Windsor, Windsor, ON, N9B 3P4, Canada
| | - Yongchao Su
- Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States
| | - Haichen Nie
- Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States
| | - Wei Xu
- Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States
| | - Dirk Stueber
- Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States
| | - Narayan Variankaval
- Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States
| | - Robert W. Schurko
- Department of Chemistry & Biochemistry, University of Windsor, Windsor, ON, N9B 3P4, Canada
| |
Collapse
|